Vanessa Piechotta

3.2k total citations
47 papers, 1.5k citations indexed

About

Vanessa Piechotta is a scholar working on Infectious Diseases, Oncology and Neurology. According to data from OpenAlex, Vanessa Piechotta has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 8 papers in Oncology and 7 papers in Neurology. Recurrent topics in Vanessa Piechotta's work include COVID-19 Clinical Research Studies (21 papers), SARS-CoV-2 and COVID-19 Research (20 papers) and Long-Term Effects of COVID-19 (7 papers). Vanessa Piechotta is often cited by papers focused on COVID-19 Clinical Research Studies (21 papers), SARS-CoV-2 and COVID-19 Research (20 papers) and Long-Term Effects of COVID-19 (7 papers). Vanessa Piechotta collaborates with scholars based in Germany, United Kingdom and Australia. Vanessa Piechotta's co-authors include Nicole Skoetz, Ina Monsef, Lise J Estcourt, Cynthia So‐Osman, Zoe McQuilten, Khai Li Chai, Erica M. Wood, Sarah J Valk, Catherine Kimber and Abigail Lamikanra and has published in prestigious journals such as Journal of Clinical Oncology, Cochrane Database of Systematic Reviews and BMJ.

In The Last Decade

Vanessa Piechotta

43 papers receiving 1.5k citations

Peers

Vanessa Piechotta

NEURO

ONCOL

James B Cutrell United States

Inderbir Padda United States

Aleksandra Marinkovic Nigeria

Priyank Desai Nigeria

Jasmine Mangat Nigeria

Thibault Fiolet France

Risha Patidar Nigeria

Yanjun Zhong China

Weina Guo China

Yanru Qiu China

James B Cutrell United States

Vanessa Piechotta

1.4k ×1.5

519 ×1.5

NEURO

167 ×1.0

ONCOL

209 ×1.4

81 ×0.6

Citations per year, relative to Vanessa Piechotta Vanessa Piechotta (= 1×) peers James B Cutrell

Countries citing papers authored by Vanessa Piechotta

Since Specialization

Citations

This map shows the geographic impact of Vanessa Piechotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Piechotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Piechotta more than expected).

Fields of papers citing papers by Vanessa Piechotta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Piechotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Piechotta. The network helps show where Vanessa Piechotta may publish in the future.

Co-authorship network of co-authors of Vanessa Piechotta

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Piechotta. A scholar is included among the top collaborators of Vanessa Piechotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Piechotta. Vanessa Piechotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Langer, P., Lukas John, Ina Monsef, et al.. (2024). Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant. Cochrane Database of Systematic Reviews. 2024(5). CD013595–CD013595. 8 indexed citations

Mikołajewska, Agata, Anna-Lena Fischer, Vanessa Piechotta, et al.. (2024). Colchicine for the treatment of COVID-19. Emergencias.

Külper‐Schiek, Wiebe, Antonia Pilic, Joerg J Meerpohl, et al.. (2024). Needs and feasibility of living systematic reviews (LSRs): Experience from LSRs on COVID-19 vaccine effectiveness. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 186. 86–91. 1 indexed citations

Siemens, Waldemar, Corinna Schaefer, Monika Nothacker, et al.. (2024). Entwicklung von Kriterien für die prospektive Einschätzung des Aktualisierungsbedarfs von Leitlinienempfehlungen: AGIL-Kriterien. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 184. 7–17. 1 indexed citations

Pilic, Antonia, et al.. (2024). How do national immunization technical advisory groups assess and use evidence: Findings from the SYSVAC survey. Vaccine. 43(Pt 2). 126538–126538. 1 indexed citations

Schmid, Yasmin, et al.. (2024). Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases. Cochrane Database of Systematic Reviews. 2024(9). CD015383–CD015383. 8 indexed citations

Heise, Daniel, Caspar Stephani, Ina Monsef, et al.. (2024). Determination of positive end-expiratory pressure in COVID-19-related acute respiratory distress syndrome. PubMed. 3(6). e0060–e0060.

Lichtner, Gregor, Claudia Spies, Thomas Bienert, et al.. (2023). Automated Monitoring of Adherence to Evidenced-Based Clinical Guideline Recommendations: Design and Implementation Study. Journal of Medical Internet Research. 25. e41177–e41177. 10 indexed citations

Piechotta, Vanessa, Nina Kreuzberger, Ina Monsef, et al.. (2023). The effectiveness of clinical guideline implementation strategies in oncology—a systematic review. BMC Health Services Research. 23(1). 347–347. 11 indexed citations

10.

Piechotta, Vanessa, Waldemar Siemens, Judith Koch, et al.. (2023). Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis. The Lancet Child & Adolescent Health. 7(6). 379–391. 47 indexed citations

11.

Külper‐Schiek, Wiebe, Vanessa Piechotta, Antonia Pilic, et al.. (2022). Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review. Frontiers in Immunology. 13. 940562–940562. 26 indexed citations

12.

Piechotta, Vanessa, Sibylle C. Mellinghoff, Claire Iannizzi, et al.. (2022). Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review. Blood Cancer Journal. 12(5). 86–86. 25 indexed citations

13.

Piechotta, Vanessa, et al.. (2022). Patients with multiple myeloma or monoclonal gammopathy of undetermined significance—diagnosis, treatment, and follow-up. Deutsches Ärzteblatt international. 119(14). 253–260. 5 indexed citations

14.

Piechotta, Vanessa, et al.. (2022). Psychedelic/entactogen-assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care. Cochrane Database of Systematic Reviews. 2022(11). 4 indexed citations

15.

Iannizzi, Claire, et al.. (2022). Interventions to increase COVID-19 vaccine uptake: a scoping review. Cochrane Database of Systematic Reviews. 2022(8). CD015270–CD015270. 28 indexed citations

16.

Iannizzi, Claire, Elie A. Akl, Lara A Kahale, et al.. (2021). Methods and guidance on conducting, reporting, publishing and appraising living systematic reviews: a scoping review protocol. F1000Research. 10. 802–802. 7 indexed citations

17.

Iannizzi, Claire, Jacob Burns, Stephanie Weibel, et al.. (2021). Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: A concept paper. Journal of Clinical Epidemiology. 141. 82–89. 27 indexed citations

18.

Wieland, L. Susan, Vanessa Piechotta, Termeh Feinberg, et al.. (2021). Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review. BMC Complementary Medicine and Therapies. 21(1). 112–112. 45 indexed citations

19.

Piechotta, Vanessa, Nicole Skoetz, Kathrin Grummich, et al.. (2021). Interventions for palliative symptom control in COVID-19 patients. Cochrane Database of Systematic Reviews. 2021(8). CD015061–CD015061. 12 indexed citations

20.

Salek, Sam, Nina Kreuzberger, Vanessa Piechotta, et al.. (2021). Patient-reported outcomes in clinical trials for multiple myeloma: Where we are.. Journal of Clinical Oncology. 39(15_suppl). e18615–e18615. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact